908 Devices Financials

MASS Stock  USD 2.78  0.22  8.59%   
Based on the key indicators related to 908 Devices' liquidity, profitability, solvency, and operating efficiency, 908 Devices is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March. At this time, 908 Devices' Short Term Debt is comparatively stable compared to the past year. Key indicators impacting 908 Devices' financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio8.016.94
Fairly Up
Slightly volatile
The financial analysis of 908 Devices is a critical element in measuring its lifeblood. Investors should not minimize 908 Devices' ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

(31.12 Million)

  

908 Devices Earnings Geography

Please note, the imprecision that can be found in 908 Devices' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of 908 Devices. Check 908 Devices' Beneish M Score to see the likelihood of 908 Devices' management manipulating its earnings.

908 Devices Stock Summary

908 Devices competes with Inari Medical, CONMED, Glaukos Corp, Nevro Corp, and Medtronic PLC. 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts. 908 Devices operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 177 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS65443P1021
CUSIP65443P102
LocationMassachusetts; U.S.A
Business Address645 Summer Street,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Website908devices.com
Phone857 254 1500
CurrencyUSD - US Dollar

908 Devices Key Financial Ratios

908 Devices Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets178.8M260.9M242.6M203.0M233.4M174.3M
Other Current Liab3.9M5.6M7.4M8.7M10.0M5.7M
Other Liab1.3M8.8M12.0M14.7M16.9M17.8M
Net Tangible Assets(63.2M)139.0M214.6M172.1M197.9M207.8M
Net Debt(137.4M)(203.2M)(172.0M)(115.1M)(103.6M)(108.8M)
Retained Earnings(78.5M)(100.6M)(134.2M)(170.6M)(153.5M)(161.2M)
Accounts Payable1.0M1.4M1.4M1.2M1.4M1.1M
Cash159.2M224.1M188.4M121.0M139.2M131.6M
Other Assets511K723K1.2M1.4M1.6M962.9K
Net Receivables6.9M16.4M10.0M9.0M10.3M9.8M
Inventory4.6M7.9M12.5M14.9M17.2M8.9M
Other Current Assets647K4.5M4.7M4.2M4.8M2.7M
Total Liab39.8M46.3M52.0M37.5M33.7M47.2M
Net Invested Capital153.9M229.6M15M165.5M190.3M199.8M
Total Current Assets171.0M252.9M215.6M173.8M199.9M157.5M
Capital Stock27K31K32K33K38.0K24.4K
Net Working Capital160.1M238.1M196.4M151.2M173.9M143.1M
Short Term Debt2.9M2.7M2.9M5.3M6.1M6.4M
Common Stock27K31K32K33K38.0K24.4K

908 Devices Key Income Statement Accounts

The reason investors look at the income statement is to determine what 908 Devices' earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
202020212022202320242025 (projected)
Net Interest Income(976K)(486K)1.9M4.5M5.1M5.4M
Interest Expense976K486K129K201K180.9K171.9K
Total Revenue26.9M42.2M46.9M50.2M57.8M37.8M
Gross Profit14.9M23.2M26.0M25.3M29.1M20.2M
Operating Income(5.8M)(22.1M)(35.4M)(42.8M)(38.5M)(36.6M)
Ebit(11.8M)(21.9M)(35.4M)(36.4M)(32.8M)(34.4M)
Research Development8.2M13.1M17.5M21.9M25.2M14.5M
Ebitda(11.0M)(20.9M)(33.8M)(34.0M)(30.6M)(32.2M)
Cost Of Revenue12.0M19.0M20.8M24.9M28.6M17.6M
Income Before Tax(12.8M)(22.2M)(33.6M)(36.6M)(32.9M)(34.6M)
Net Income(6.9M)(22.1M)(31.7M)(36.4M)(32.8M)(31.1M)
Income Tax Expense(5.9M)(53K)(1.8M)(211K)(189.9K)(199.4K)

908 Devices Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory223K(4.5M)(5.5M)(3.9M)(3.5M)(3.7M)
Investments(9K)(737K)(15.8M)(31.6M)(28.5M)(27.1M)
Change In Cash141.3M64.9M(35.5M)(67.4M)(60.6M)(57.6M)
Free Cash Flow4.1M(29.8M)(23.0M)(27.1M)(24.4M)(25.6M)
Depreciation831K925K1.6M2.4M2.7M1.4M
Other Non Cash Items(687K)178K584K1.0M1.2M1.3M
Capital Expenditures392K9K737K2.0M2.4M2.5M
Net Income(12.8M)(22.2M)(33.6M)(36.4M)(32.8M)(34.4M)
End Period Cash Flow159.2M224.1M188.6M121.2M139.4M131.7M
Change To Netincome727K6.1M4.6M7.5M8.6M4.4M

908 Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining 908 Devices's current stock value. Our valuation model uses many indicators to compare 908 Devices value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 908 Devices competition to find correlations between indicators driving 908 Devices's intrinsic value. More Info.
908 Devices is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, 908 Devices' Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value 908 Devices by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

908 Devices Systematic Risk

908 Devices' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. 908 Devices volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on 908 Devices correlated with the market. If Beta is less than 0 908 Devices generally moves in the opposite direction as compared to the market. If 908 Devices Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one 908 Devices is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of 908 Devices is generally in the same direction as the market. If Beta > 1 908 Devices moves generally in the same direction as, but more than the movement of the benchmark.

908 Devices Thematic Clasifications

908 Devices is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
DrugsView
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
Today, most investors in 908 Devices Stock are looking for potential investment opportunities by analyzing not only static indicators but also various 908 Devices' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of 908 Devices growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.91)

At this time, 908 Devices' Price Earnings To Growth Ratio is comparatively stable compared to the past year.

908 Devices February 16, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of 908 Devices help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of 908 Devices. We use our internally-developed statistical techniques to arrive at the intrinsic value of 908 Devices based on widely used predictive technical indicators. In general, we focus on analyzing 908 Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build 908 Devices's daily price indicators and compare them against related drivers.

Additional Tools for 908 Stock Analysis

When running 908 Devices' price analysis, check to measure 908 Devices' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 908 Devices is operating at the current time. Most of 908 Devices' value examination focuses on studying past and present price action to predict the probability of 908 Devices' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 908 Devices' price. Additionally, you may evaluate how the addition of 908 Devices to your portfolios can decrease your overall portfolio volatility.